The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1126
ISSUE 1126
March 18, 2002
Issue 1126
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Ertapenem (Invanz) - A New Parenteral Carbapenem
March 18, 2002 (Issue: 1126)
Ertapenem (er ta pen' em; Invanz - Merck), a carbapenem antibacterial with a narrower spectrum of activity than imipenem (Primaxin) or meropenem (Merrem), has been approved by the FDA for once-daily IV treatment of complicated intra-abdominal,...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.